Search Tag: Oxford Biomedics
2020 08 Jun
UK-based drugmaker AstraZeneca expands its plans with regard to the COVID-19 vaccine, doubling its manufacturing capacity to 2 billion doses and securing deals with a number of partners. You might also like: EU Supports Clinical Trials During COVID-19 The vaccine, AZD1222 (previously known as ChAdOx1 nCoV-19), was developed...Read more